Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bosco Paes

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Human Vaccines & Immunotherapeutics|December 18, 2024
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panelBosco Paes, Vivien Brown, Erin Courtney, et al.
The Pediatric Infectious Disease Journal|October 19, 2016
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus SeasonsEvan J Anderson, Xavier Carbonell-Estrany, Maarten Blanken, et al.
Pediatric Pulmonology|February 7, 2018
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infantsMaarten O Blanken, Bosco Paes, Evan J Anderson, et al.
CMAJ Open|December 27, 2016
Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort studyAnna Banerji, Val Panzov, Michael Young, et al.
Cost Effectiveness and Resource Allocation : C/E|January 28, 2026
Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infantsCarlos E Rodriguez-Martinez, Jaime Ordonez, Xavier Carbonell-Estrany, et al.
Frontiers in Public Health|October 13, 2023
Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, CanadaElisabeth Mercier, Lakshmi Pisharody, Fiona Guy, et al.
Frontiers in Public Health|February 9, 2024
Corrigendum: Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, CanadaElisabeth Mercier, Lakshmi Pisharody, Fiona Guy, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestationBarbara J Law, Joanne M Langley, Upton Allen, et al.
Open Forum Infectious Diseases|July 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) TaskforcePaolo Manzoni, Eugenio Baraldi, Fabio Midulla, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Human Vaccines & Immunotherapeutics|December 18, 2024
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panelBosco Paes, Vivien Brown, Erin Courtney, et al.
The Pediatric Infectious Disease Journal|October 19, 2016
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus SeasonsEvan J Anderson, Xavier Carbonell-Estrany, Maarten Blanken, et al.
Pediatric Pulmonology|February 7, 2018
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infantsMaarten O Blanken, Bosco Paes, Evan J Anderson, et al.
CMAJ Open|December 27, 2016
Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort studyAnna Banerji, Val Panzov, Michael Young, et al.
Cost Effectiveness and Resource Allocation : C/E|January 28, 2026
Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infantsCarlos E Rodriguez-Martinez, Jaime Ordonez, Xavier Carbonell-Estrany, et al.
Frontiers in Public Health|October 13, 2023
Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, CanadaElisabeth Mercier, Lakshmi Pisharody, Fiona Guy, et al.
Frontiers in Public Health|February 9, 2024
Corrigendum: Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, CanadaElisabeth Mercier, Lakshmi Pisharody, Fiona Guy, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestationBarbara J Law, Joanne M Langley, Upton Allen, et al.
Open Forum Infectious Diseases|July 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) TaskforcePaolo Manzoni, Eugenio Baraldi, Fabio Midulla, et al.
Pageof 12